Cancer is considered to be the second largest reason of death in the U.S. after heart disease, with roughly one in every four deaths linked to some form of cancer. Time and again, cancer is cured with radiation therapy (used in about 50% of all treatments), either alone or in grouping with surgery or chemotherapy. At present, the most widely used radiotherapy uses X-rays delivered by external beams administered using linear accelerators.
The World Health Organization (WHO) estimates that the annual incidence of cancer is expected to increase 50% to 15 million cases annually by 2020.The aging of the baby boomer population in the U.S. and the overall growth in the elderly population around the world is one of the main factors that will drive future growth in the market.
Most of the international markets are under-equipped with radiation therapy systems to deal with the growing cancer incidence. Cancer patients in a number of foreign countries must often endure long waits for radiotherapy treatment. Many of these countries are expanding and improving their radiotherapy services to take care of their cancer patients, which represent additional drivers for continued growth in the international markets.
The report focuses on the global radiotherapy equipment market - its segments, value, growth rate, opportunities, drivers etc. The Europe and Asian radiotherapy equipment market have been covered separately. It also discusses linear accelerator’s market overview and projections.
The report profiles some of the key industry players, including their financial information, key business strategies, etc.
(0 items)
